LOBELIA INFLATA

N/A

Manufactured by Boiron

22 FDA adverse event reports analyzed

Last updated: 2026-04-15

About LOBELIA INFLATA

LOBELIA INFLATA is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Boiron. The most commonly reported adverse reactions for LOBELIA INFLATA include ABDOMINAL PAIN UPPER, BLISTER, COUGH, DIARRHOEA, DRUG LEVEL DECREASED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for LOBELIA INFLATA.

Top Adverse Reactions

ABDOMINAL PAIN UPPER1 reports
BLISTER1 reports
COUGH1 reports
DIARRHOEA1 reports
DRUG LEVEL DECREASED1 reports
ERYTHEMA1 reports
INFECTION1 reports
MOOD ALTERED1 reports
NAUSEA1 reports
OCULAR HYPERAEMIA1 reports
PANNICULITIS1 reports
PURULENT DISCHARGE1 reports
PYREXIA1 reports
RASH GENERALISED1 reports
SEASONAL ALLERGY1 reports
SKIN INDURATION1 reports
SKIN INFECTION1 reports
SKIN MASS1 reports
SKIN WARM1 reports
STREPTOCOCCAL INFECTION1 reports
VOMITING1 reports
WOUND1 reports

Report Outcomes

Out of 1 classified reports for LOBELIA INFLATA:

Serious 100.0%Non-Serious 0.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male1 (100.0%)

Reports by Age

Age 181 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with LOBELIA INFLATA?

This profile reflects 22 FDA FAERS reports that mention LOBELIA INFLATA. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for LOBELIA INFLATA?

Frequently reported terms in FAERS include ABDOMINAL PAIN UPPER, BLISTER, COUGH, DIARRHOEA, DRUG LEVEL DECREASED, ERYTHEMA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures LOBELIA INFLATA?

Labeling and FAERS entries often list Boiron in connection with LOBELIA INFLATA. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.